Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatomegaly”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Testing effectiveness (Phase 2)Ended earlyNCT02421354
What this trial is testing

Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis

Who this might be right for
HepatomegalyMyelofibrosis Transformation in Essential ThrombocythemiaPolycythemia Vera, Post-Polycythemic Myelofibrosis Phase+2 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Looking for participantsNCT04988945
What this trial is testing

TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma

Who this might be right for
HCC
The University of Hong Kong 33
Large-scale testing (Phase 3)Study completedNCT00565097
What this trial is testing

Lanreotide as Treatment of Polycystic Livers

Who this might be right for
Polycystic Liver DiseaseHepatomegalyLiver Diseases+1 more
Radboud University Medical Center 38
Not applicableLooking for participantsNCT07068191
What this trial is testing

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more
Phenomen Pharma 90
Large-scale testing (Phase 3)UnknownNCT00771888
What this trial is testing

Open-Label Extension of LOCKCYST Trial

Who this might be right for
Polycystic Liver DiseaseHepatomegalyLiver Diseases+2 more
Radboud University Medical Center 54
Testing effectiveness (Phase 2)Study completedNCT03499808
What this trial is testing

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Who this might be right for
Amorphous, Eosinophilic, and Acellular DepositConstipationDiarrhea+10 more
SWOG Cancer Research Network 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT03801434
What this trial is testing

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

Who this might be right for
BCR-JAK2 Fusion Protein ExpressionBlasts 20 Percent or Less of Peripheral Blood White CellsBlasts More Than 5 Percent of Bone Marrow Nucleated Cells+9 more
Stanford University 8
Not applicableWithdrawnNCT01331642
What this trial is testing

Biomarker for Gaucher Disease: BioGaucher (BioGaucher)

Who this might be right for
SplenomegalyHepatomegaly
CENTOGENE GmbH Rostock
Not applicableWithdrawnNCT02298699
What this trial is testing

Biomarker for Sly Disease (MPS VII) (BioSly)

Who this might be right for
Developmental DelaySkeletal AbnormalitiesHepatomegaly+1 more
CENTOGENE GmbH Rostock
Not applicableUnknownNCT05103007
What this trial is testing

PVE/PVL Combined With DEB-TACE in the Treatment of Patients With Large and Unresectable Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Tongji Hospital 200
Large-scale testing (Phase 3)Study completedNCT00426153
What this trial is testing

Octreotide in Severe Polycystic Liver Disease

Who this might be right for
Polycystic Kidney, Autosomal DominantPolycystic Liver DiseaseHepatomegaly+3 more
Mayo Clinic 42
Not applicableUnknownNCT03666117
What this trial is testing

Prevalence of Hepatomegaly in Children and Adolescents With Type 1 Diabetes Mellitus

Who this might be right for
Hepatomegaly
Assiut University 60
Not applicableNo Longer AvailableNCT00962260
What this trial is testing

Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease

Who this might be right for
Gaucher Disease
Pfizer
Not applicableWithdrawnNCT02298634
What this trial is testing

Biomarker for Farber Disease (BioFarber)

Who this might be right for
Farber's LipogranulomatosisCeramidase DeficiencyHepatomegaly+1 more
CENTOGENE GmbH Rostock